Why is Akums Drugs falling/rising?

As of 07-Aug, Akums Drugs & Pharmaceuticals Ltd is currently priced at 490.65, reflecting a rise of 1.7 (0.35%). The stock has recently experienced a trend reversal, gaining after six consecutive days of decline. However, it has underperformed its sector by 0.3% today. The stock touched an intraday low of Rs 478.05, indicating a drop of 2.23%. Over the past week, the stock has decreased by 5.42%, and over the past month, it has fallen by 13.73%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, and there has been a significant decline in investor participation, with delivery volume dropping by 68.12% against the 5-day average. There are no positive or negative factors provided to further explain the stock's recent movement.
Broader market context shows that while Akums Drugs has faced a substantial decline of 23.11% year-to-date, the benchmark Sensex has gained 3.18% in the same period. In the short term, the stock's performance has been notably weaker than the benchmark, with a 1-week return of -5.42% compared to the Sensex's -0.69%. This stark contrast highlights the stock's struggles relative to the broader market, contributing to the perception of weakness among investors.